SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease

Background: Urinary symptoms are common, disabling and generally unresponsive to treatment in Parkinson´s disease (PD). Safinamide is approved as an add-on therapy to levodopa to improve fluctuations. Methods: Retrospective analysis of electronic records of nondemented PD patients seen consecutively...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez-López, Ana, Sánchez-Sánchez, Arantxa, Natera-Villalba, Elena, Ros-Castelló, Victoria, Beltrán-Corbellini, Álvaro, Fanjul-Arbós, Samira, Pareés Moreno, Isabel, López-Sendon Moreno, José Luis, Martínez Castrillo, Juan Carlos, Alonso-Canovas, Araceli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825064/
https://www.ncbi.nlm.nih.gov/pubmed/33418858
http://dx.doi.org/10.3390/brainsci11010057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825064/
https://www.ncbi.nlm.nih.gov/pubmed/33418858
http://dx.doi.org/10.3390/brainsci11010057

Ejemplares similares